Page 24 - Read Online

Castán et al. Radiology of hepatocarcinoma in non-cirrhotic patients

2010;52:1723-30. Cirrhosis: modified caudate-right lobe ratio. Radiology 2002;224:769-
7. Seale MK, Catalano OA, Saini S, Hahn PF, Sahani DV. Hepatobiliary- 74.
specific MR contrast agents: role in imaging the liver and biliary tree. 23. Harbin WP, Robert NJ, Ferrucci JT. Diagnosis of cirrhosis based
Radiographics 2009;29:1725-48. on regional changes in hepatic morphology: a radiological and
8. Kim MJ, Rhee HJ, Jeong HT. Hyperintense lesions on gadoxetate pathological analysis. Radiology 1980;135:273-83.
disodium-enhanced hepatobiliary phase imaging. AJR Am J Roentgenol 24. Giorgio A, Amoroso P, Lettieri G, Fico P, de Stefano G, Finelli L,
2012;199:W575-86. Scala V, Tarantino L, Pierri P, Pesce G. Cirrhosis: value of caudate to
9. Tsuboyama T, Onishi H, Kim T, Akita H, Hori M, Tatsumi M, right lobe ratio in diagnosis with US. Radiology 1986;161:443-5.
Nakamoto A, Nagano H, Matsuura N, Wakasa K, Tomoda K. 25. Hess CF, Schmiedl U, Koelbel G, Knecht R, Kurtz B. Diagnosis of
Hepatocellular carcinoma: hepatocyte-selective enhancement at liver cirrhosis with US: receiver-operating characteristic analysis of
gadoxetic acid-enhanced MR imaging--correlation with expression multidimensional caudate lobe indexes. Radiology 1989;171:349-51.
of sinusoidal and canalicular transporters and bile accumulation. 26. Sanford NL, Walsh P, Matis C, Baddeley H, Powell LW. Is
Radiology 2010;255:824-33. ultrasonography useful in the assessment of diffuse parenchymal liver
10. European Association For The Study Of The Liver; European disease? Gastroenterology 1985;89:186-91.
Organisation For Research And Treatment Of Cancer. EASL-EORTC 27. Bluth E, Arger P, Benson C, Ralls P, Siegel M. Ultrasound, a practical
clinical practice guidelines: management of hepatocellular carcinoma. approach to clinical problems. New York: Thieme Publishing Group;
J Hepatol 2012;56:908-43. 2008. p.36.
11. Jang HJ, Kim TK, Burns PN, Wilson SR. Enhancement patterns of 28. McGahan J, Goldberg B. Diagnostic ultrasound. New York: Informa
hepatocellular carcinoma at contrast-enhanced US: comparison with Healthcare; 2008.
histologic differentiation. Radiology 2007;244:898-906. 29. Robinson KA, Middleton WD, Al-Sukaiti R, Teefey SA, Dahiya N.
12. Wilson SR, Kim TK, Jang HJ, Burns PN. Enhancement patterns Doppler sonography of portal hypertension. Ultrasound Q 2009;25:3-
of focal liver masses: discordance between contrast-enhanced 13.
sonography and contrast-enhanced CT and MRI. AJR Am J Roentgenol 30. Lin DY, Sheen IS, Chiu CT, Lin SM, Kuo YC, Liaw YF.
2007;189:W7-12. Ultrasonographic changes of early liver cirrhosis in chronic hepatitis B:
13. Giorgio A, Ferraioli G, Tarantino L, de Stefano G, Scala V, Scarano F, a longitudinal study. J Clin Ultrasound 1993;21:303-8.
Coppola C, Del Viscovo L. Contrast-enhanced sonographic appearance 31. Afdhal NH. Fibroscan (transient elastography) for the measurement of
of hepatocellular carcinoma in patients with cirrhosis: comparison liver fibrosis. Gastroenterol Hepatol (N Y) 2012;8:605-7.
with contrast-enhanced helical CT appearance. AJR Am J Roentgenol 32. Ganne-Carrié N, Ziol M, de Ledinghen V, Douvin C, Marcellin P,
2004;183:1319-26. Castera L, Dhumeaux D, Trinchet JC, Beaugrand M. Accuracy of liver
14. Liu JJ, Li HX, Chen ZB, Yang WP, Zhao SF, Chen J, Bai T, Li H, stiffness measurement for the diagnosis of cirrhosis in patients with
Li LQ. Consistency analysis of contrast-enhanced ultrasound and chronic liver diseases. Hepatology 2006;44:1511-7.
contrast-enhanced CT in diagnosis of small hepatocellular carcinoma. 33. Sporea I, Badea R, Sirli R, Lupsor M, Popescu A, Danila M, Focsa
Int J Clin Exp Med 2015;8:21466-71. M, Deleanu A. How efficient is acoustic radiation force impulse
15. Liu GJ, Wang W, Lu MD, Xie XY, Xu HX, Xu ZF, Chen LD, Wang elastography for the evaluation of liver stiffness? Hepat Mon
Z, Liang JY, Huang Y, Li W, Liu JY. Contrast-enhanced ultrasound 2011;11:532-8.
for the characterization of hepatocellular carcinoma and intrahepatic 34. Ito K, Mitchell DG, Gabata T. Enlargement of hilar periportal space:
cholangiocarcinoma. Liver Cancer 2015;4:241-52. a sign of early cirrhosis at MR imaging. J Magn Reson Imaging
16. Ohno N, Miyati T, Yamashita M, Narikawa M. Quantitative 2000;11:136-40.
assessment of tissue perfusion in hepatocellular carcinoma using 35. Wang Y, Ganger DR, Levitsky J, Sternick LA, McCarthy RJ, Chen
perflubutane dynamic contrast-enhanced ultrasonography: a ZE, Fasanati CW, Bolster B, Shah S, Zuehlsdorff S, Omary RA,
preliminary study. Diagnostics 2015;5:210-8. Ehman RL, Miller FH. Assessment of chronic hepatitis and fibrosis:
17. Spârchez Z, Radu P, Kacso G, Spârchez M, Zaharia T, Al Hajjar N. comparison of MR elastography and diffusion-weighted imaging. AJR
Prospective comparison between real time contrast enhanced and Am J Roentgenol 2011;196:553-61.
conventional ultrasound guidance in percutaneous biopsies of liver 36. Bakan AA, Inci E, Bakan S, Gokturk S, Cimilli T. Utility of diffusion-
tumors. Med Ultrason 2015;17:456-63. weighted imaging in the evaluation of liver fibrosis. Eur Radiol
18. Roccarina D, Garcovich M, Ainora ME, Riccardi L, Pompili M, 2012;22:682-7.
Gasbarrini A, Zocco MA. Usefulness of contrast enhanced ultrasound 37. Sandrasegaran K, Akisik FM, Lin C, Tahir B, Rajan J, Saxena R,
in monitoring therapeutic response after hepatocellular carcinoma Aisen AM. Value of diffusion-weighted MRI for assessing liver
treatment. World J Hepatol 2015;7:1866-74. fibrosis and cirrhosis. AJR Am J Roentgenol 2009;193:1556-60.
19. Gao Y, Zheng DY, Cui Z, Ma Y, Liu YZ, Zhang W. Predictive 38. Hagiwara M, Rusinek H, Lee VS, Losada M, Bannan MA, Krinsky
value of quantitative contrast-enhanced ultrasound in hepatocellular GA, Taouli B. Advanced liver fibrosis: diagnosis with 3D whole-liver
carcinoma recurrence after ablation. World J Gastroenterol perfusion MR imaging--initial experience. Radiology 2008;246:926-
2015;21:10418-26. 34.
20. Xia Y, Kudo M, Minami Y, Hatanaka K, Ueshima K, Chung H, 39. Gressner AM, Weiskirchen R. Modern pathogenetic concepts of
Hagiwara S, Inoue T, Ishikawa E, Kitai S, Takahashi S, Tatsumi C, liver fibrosis suggest stellate cells and TGF-beta as major players and
Ueda T, Hayaishi S, Maekawa K: Response evaluation of transcatheter therapeutic targets. J Cell Mol Med 2006;10:76-99.
arterial chemoembolization in hepatocellular carcinomas: the 40. Göbel T, Schadewaldt-Tümmers J, Greiner L, Poremba C, Häussinger
usefulness of sonazoid-enhanced harmonic sonography. Oncology D, Erhardt A. Transient elastography improves detection of liver
2008;75:99-105. cirrhosis compared to routine screening tests. World J Gastroenterol
21. Bruix J, Sherman M; American Association for the Study of Liver 2015;21:953-60.
Diseases. Management of hepatocellular carcinoma: an update. 41. Afdhal NH, Nunes D. Evaluation of liver fibrosis: a concise review.
Hepatology 2011;53:1020-2. Am J Gastroenterol 2004;99:1160-74.
22. Awaya H, Mitchell DG, Kamishima T, Holland G, Ito K, Matsumoto T. 42. Macarini L, Stoppino L. Practical management of chronic viral
16 Hepatoma Research ¦ Volume 3 ¦ January 12, 2017